Morepen Laboratories Ltd has increased its holding in Doctors Morepen Ltd (DML), which was earlier, hived off as an Independent company. The company has converted its outstanding preference Capital of Rs 657.40 million in DML into Equity capital and its holding has jumped up from 13.95% to 83.44%. With this majority shift, DML has become subsidiary of the company and the popular brand Dr. Morepen comes back under the folds of the company, according to a company release.

"Dr. Morepen brand coming back to our kitty gives immense presence in the domestic market in terms of brand and the distribution network and also Dr. Morepen's OTC range gives us a ready product basket for export of OTC product," said Sushil Suri, CMD the Company.

DML was hived off earlier for growth in the FMCG segment but looking at emerging opportunity in the pharma sector, Dr. Morepen brand will be now focus exclusively on health and of pharma products under Company's banner, added the release.